Cytotoxic effects induced by unmodified and organically modified nanoclays in the human hepatic HepG2 cell line

Journal of Applied Toxicology

Volumn 31, Issue 1, 2011, Pages 27-35

  Lordan, Sinéad ^a   Kennedy, James E ^a   Higginbotham, Clement L ^a  

^a Athletic Rehabilitation Therapy Ireland   (Ireland)

Author keywords

Cytotoxicity; Montmorillonite; Nanoclays; Nanoparticles; Organoclays; Reactive oxygen species

Indexed keywords

CASPASE 3; CASPASE 7; CLOISITE 93A; CLOISITE SODIUM ION; NANOPARTICLE; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ARTICLE; CELL DEATH; CELL MEMBRANE; CELL STRAIN HEPG2; CELL VIABILITY; CULTURE MEDIUM; DRUG CYTOTOXICITY; HEALTH HAZARD; HEPATOMA CELL; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; INFRARED SPECTROSCOPY; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY;

APOPTOSIS; BENTONITE; CASPASE 3; CASPASE 7; CELL SURVIVAL; HEP G2 CELLS; HUMANS; NANOPARTICLES; REACTIVE OXYGEN SPECIES;

EID: 78650493198     PISSN: 0260437X     EISSN: 10991263     Source Type: Journal    
DOI: 10.1002/jat.1564     Document Type: Article

References (52)

1. Atai M, Solhi L, Nodehi A, Mirabedini SM, Kasraei S, Akbari K, Babanzadeh S. 2009. PMMA-grafted nanoclay as novel filler for dental adhesives. Dent. Mater. 25: 339-347; doi: 10.1016/j.dental.2008.08.005.
2. Barillet S, Jugan ML, Simon-Deckers A, Leconte Y, Herlin-Boime N, Mayne-l'Hermite M, Reynaud C, Carrière M. 2009. SiC nanoparticles cyto- and genotoxicity to Hep-G2 cells. J. Phys.: Conf. Ser. 170: 012016; doi: 10.1088/1742-6596/170/1/012016.
3. Burczynski ME, McMillian M, Ciervo J, Li L, Parker JB, Dunn II RT, Hicken S, Farr S, Johnson MD. 2000. Toxicogenomics-based discrimination of toxic mechanism in HepG2 human hepatoma cells. Toxicol. Sci. 58: 399-415.
4. Campbell K, Craig DQM, McNally T. 2008. Poly(ethylene glycol) layered silicate nanocomposites for retarded drug release prepared by hot-melt extrusion. Int. J. Pharm. 363: 126-131; doi: 10.1016/j.ijpharm.2008.06.027.
5. Casey A, Herzog E, Davoren M, Lyng FM, Byrne HJ, and Chambers G. 2007. Spectroscopic analysis confirms the interactions between single walled carbon nanotubes and various dyes commonly used to assess cytotoxicity. Carbon 45: 1425-1432; doi: 10.1016/j.carbon.2007.03.033.
6. Davoren M, Herzog E, Casey A, Cottineau B, Chambers G, Byrne HJ, Lyng FM. 2007. In vitro toxicity evaluation of single walled carbon nanotubes on human A549 lung cells. Toxicol. in Vitro 21: 438-448; doi: 10.1016/j.tiv.2006.10.007.
7. de Azeredo HMC. 2009. Nanocomposites for food packaging applications. Food Res. Int. 42: 1240-1253; doi: 10.1016/j.foodres.2009.03.019.
8. Di Pasqua AJ, Sharma KK, Shi YL, Toms BB, Ouellette W, Dabrowiak JC, Asefa T. 2008. Cytotoxicity of mesoporous silica nanomaterials. J. Inorg. Biochem. 102: 1416-1423; doi: 10.1016/j.jinorgbio.2007.12.028.
9. Fernández-Urrusuno R, Fattal E, Féger J, Couvreur P, Thérond P. 1997. Evaluation of hepatic antioxidant systems after intravenous administration of polymeric nanoparticles. Biomaterials 18: 511-517; doi: 10.1016/S0142-9612(96)00178-0.
10. Fischer HC, Chan WCW. 2007. Nanotoxicity: the growing need for in vivo study. Curr. Opin. Biotechnol. 18: 565-571; doi: 10.1016/j.copbio.2007.11.008.
11. Fubini B, Hubbard A. 2003. Reactive oxygen species (ROS) and reactive nitrogen species (RNS) generation by silica in inflammation and fibrosis. Free Radic. Biol. Med. 34: 1507-1516; doi: 10.1016/S0891-5849(03)00149-7.
12. Gatti AM, Rivasi F. 2002. Biocompatibility of micro- and nanoparticles. Part I: in liver and kidney. Biomaterials 23: 2381-2387.
13. Hermosin MC, Cornejo J. 1993. Binding mechanism of 2, 4-dichlorophenoxyacetic acid by organo-clays. J. Environ. Qual. 22: 325-331.
14. Hoet PHM, Brüske-Hohlfeld I, Salata OV. 2004. Nanoparticles - known and unknown health risks. J. Nanobiotechnology 2: 12; doi: 10.1186/1477-3155-2-12.
15. Hong S, Hessler JA, Banaszak Holl MM, Leroueil P, Mecke A, Orr BG. 2006. Physical interactions of nanoparticles with biological membranes: the observation of nanoscale hole formation. Chem. Health Saf. 13: 16-20; doi: 10.1016/j.chs.2005.09.004.
16. Hunter DL, Kamena KW, Paul DR. 2007. Processing and properties of polymers modified by clays. MRS Bull. 32: 323-327.
17. Jan E, Byrne SJ, Cuddihy M, Davies AM, Volkov Y, Gun'ko YK, Kotov NA. 2008. High-content screening as a universal tool for fingerprinting of cytotoxicity of nanoparticles. ACS Nano 2: 928-938; doi: 10.1021/nn7004393.
18. Jani P, Halbert GW, Langridge J, Florence AT. 1990. Nanoparticle uptake by the rat gastrointestinal mucosa: quantitation and particle size dependency. J. Pharm. Pharmacol. 42: 821-826.
19. Jones CF, Grainger DW. 2009. In vitro assessments of nanomaterial toxicity. Adv. Drug Deliv. Rev. 61: 438-456; doi: 10.1016/j.addr.2009.03.005.
20. Karlsson HL, Gustafsson J, Cronholm P, Möller L. 2009. Size-dependent toxicity of metal oxide particles - a comparison between nano- and micrometer size. Toxicol. Lett. 188: 112-118; doi: 10.1016/j.toxlet.2009.03.014.
21. Kim S, Choi JE, Choi J, Chung KH, Park K, Yi J, Ryu DY. 2009. Oxidative stress-dependent toxicity of silver nanoparticles in human hepatoma cells. Toxicol. in Vitro 23: 1076-1084; doi: 10.1016/j.tiv.2009.06.001.
22. Korzezeniewki C, Callewaert DM. 1983. An enzyme-release assay for natural cytotoxicity. J. Immunol. Meth. 64: 313-320.
23. Kroll A, Pillukat MH, Hahn D, Schnekenburger J. 2009. Current in vitro methods in nanoparticle risk assessment: Limitations and challenges. Eur. J. Pharm. Biopharm. 72: 370-377; doi: 10.1016/j.ejpb.2008.08.009.
24. Kühnel D, Busch W, Meiβner T, Springer A, Potthoff A, Richter V, Gelinsky M, Scholz S, Schirmer K. 2009. Agglomeration of tungsten carbide nanoparticles in exposure medium does not prevent uptake and toxicity toward a rainbow trout gill cell line. Aquat. Toxicol. 93: 91-99; doi: 10.1016/j.aquatox.2009.04.003.
25. 3 nanoparticles on cells cultured on ethylene vinyl acetate substrates and fibers. Biomaterials 30: 8-18; doi: 10.1016/j.biomaterials.2008.09.015.
26. Liao M, Xie XM. 2004. Adsorption of phenoate and acetochlor from water by clays and organoclays. J. Environ. Sci. (China) 16: 738-741.
27. Lison D, Thomassen LCJ, Rabolli V, Gonzalez L, Napierska D, Seo JW, Kirsch-Volders M, Hoet P, Kirschhock CEA, Martens JA. 2008. Nominal and effective dosimetry of silica nanoparticles in cytotoxicity assays. Toxicol. Sci. 104: 155-162; doi: 10.1093/toxsci/kfn072.
28. Liu KH, Liu TY, Chen SY, Liu DM. 2008. Drug release behavior of chitosan-montmorillonite nanocomposites hydrogels following electrostimulation. Acta Biomater. 4: 1038-1045; doi: 10.1016/j.actbio.2008.01.012.
29. Lyons JG, Holehonnur H, Devine DM, Kennedy JE, Geever LM, Blackie P, Higginbotham CL. 2007. The incorporation of an organically modified layered silicate in monolithic polymeric matrices produced using hot melt extrusion. Mater. Chem. Phys. 103: 419-426; doi: 10.1016/j.matchemphys.2007.02.080.
30. Monteiro-Riviere NA, Inman AO. 2006. Challenges for assessing carbon nanomaterial toxicity to the skin. Carbon 44: 1070-1078; doi: 10.1016/j.carbon.2005.11.004.
31. Mowles JM. 1990. Mycoplasma detection. In Methods in Molecular Biology, Volume v, Animal Cell Culture, Pollard JW, Walker JM (eds). Humana Press: Totawa, NJ; 65-74.
32. Nel A, Xia T, Mädler L, Li N. 2006. Toxic potential of materials at the nanolevel. Science 311: 622-627; doi: 10.1126/science.1114397.
33. Nikula KJ, Avila KJ, Griffith WC, Mauderly JL. 1997. Lung tissue responses and sites of particle retention differ between rats and cynomolgus monkeys exposed chronically to diesel exhaust and coal dust. Fundam. Appl. Toxicol. 37: 37-53; doi: 10.1006/faat.1997.2297.
34. Oberdörster G, Stone V, Donaldson K. 2007. Toxicology of nanoparticles: a historical perspective. Nanotoxicology 1: 2-25; doi: 10.1080/17435390701314761.
35. Papis E, Rossi F, Raspanti M, Dalle-Donne I, Colombo G, Milzani A, Bernardini G, Gornati R. 2009. Engineered cobalt oxide nanoparticles readily enter cells. Toxicol. Lett. 189: 253-259; doi: 10.1016/j.toxlet.2009.06.851.
36. Park JK, Choy YB, Oh JM, Kim JY, Hwang SJ, Choy JH. 2008. Controlled release of donepezil intercalated in smectite clays. Int. J. Pharm. 359: 198-204; doi: 10.1016/j.ijpharm.2008.04.012.
37. Park MVDZ, Annema W, Salvati A, Lesniak A, Elsaesser A, Barnes C, McKerr G, Howard CV, Lynch I, Dawson KA, Piersma AH, de Jong WH. 2009. In vitro developmental toxicity test detects inhibition of stem cell differentiation by silica nanoparticles. Toxicol. Appl. Pharmacol. 240: 108-116; doi: 10.1016/j.taap.2009.07.019.
38. Patel HA, Somani RS, Bajaj HC, Jasra RV. 2006. Nanoclays for polymer nanocomposites, paints, inks, greases and cosmetics formulations, drug delivery vehicle and waste water treatment. Bull. Mater. Sci. 29: 133-145; doi: 10.1007/BF02704606.
39. Pereira de Abreu DA, Paseiro Losada P, Angulo I, Cruz JM. 2007. Development of new polyolefin films with nanoclays for application in food packaging. Eur. Polym. J. 43: 2229-2243; doi: 10.1016/j.eurpolymj.2007.01.021.
40. Riss TL, Moravec RA, O'Brien MA, Hawkins EM, Niles A. 2006. Homogenous multiwell assays for measuring cell viability, cytotoxicity, and apoptosis. In Handbook of Assay Development in Drug Discovery, Minor LK (ed.). CRC Press: Boca Raton, FL; 385-405.
41. Roth S, Langguth P, Spicher K, Enzmann H. 2008. Comparative toxicity and cell-tissue distribution study on nanoparticular iron complexes using avian embryos and HepG2-cells. Transl. Res. 151: 36-44; doi: 10.1016/j.trsl.2007.09.001.
42. Sánchez-Camazano M, Sánchez-Martín MJ. 1994. Organo-clays as adsorbents for azinphosmethyl and dichlorvos in aqueous medium. Water Air Soil Pollut. 74: 19-28.
43. Say R, Birlik E, Erdemgil Z, Denizli A, Ersöz A. 2008. Removal of mercury species with dithiocarbamate-anchored polymer/organosmectite composites. J. Hazard. Mater. 150: 560-564. DOI:10.1016/j.jhazmat.2007.03.089.
44. Seaton A, Tran L, Aitken R, Donaldson K. 2010. Nanoparticles, human health hazard and regulation. J. R. Soc. Interface 7: S119-S129; doi: 10.1098/rsif.2009.0252.focus.
45. Sozer N, Kokini JL. 2009. Nanotechnology and its applications in the food sector. Trends Biotechnol. 27: 82-89; doi: 10.1016/j.tibtech.2008.10.010.
46. Stern ST, McNeil SE. 2008. Nanotechnology safety concerns revisited. Toxicol. Sci. 101: 4-21; doi: 10.1093/toxsci/kfm169.
47. Valko M, Leibfritz D, Moncol J, Cronin MTD, Mazur M, Telser J. 2007. Free radicals and antioxidants in normal physiological functions and human disease. Int. J. Biochem. Cell Biol. 39: 44-84; doi: 10.1016/j.biocel.2006.07.001.
48. Wang H, Joseph JA. 1999. Quantifying cellular oxidative stress by dichlorofluorescein assay using microplate reader. Free Radic. Biol. Med. 27: 612-616.
49. Watanabe M, Hitomi M, van der Wee K, Rothenberg F, Fisher SA, Zucker R, Svoboda KKH, Goldsmith EC, Heiskanen KM, Nieminen AL. 2002. The pros and cons of apoptosis assays for use in the study of cells, tissues, and organs. Microsc. Microanal. 8: 375-391; doi: 10.1017/S1431927602010346.
50. Wiles MC, Huebner HJ, McDonald TJ, Donnelly KC, Phillips TD. 2005. Matrix-immobilized organoclays for the sorption of polycyclic aromatic hydrocarbons and pentachlorophenol from groundwater. Chemosphere 59: 1455-1464; doi: 10.1016/j.chemosphere.2004.12.022.
51. Wörle-Knirsch JM, Pulskamp K, Krug HF. 2006. Oops they did it again! Carbon nanotubes hoax scientists in viability assays. Nano Lett. 6: 1261-1268; doi: 10.1021/nl060177c.
52. Yuan Q, Shah J, Hein S, Misra RDK. 2010. Controlled and extended drug release behavior of chitosan-based nanoparticle carrier. Acta Biomater. 6: 1140-1148. doi: 10.1016/j.actbio.2009.08.027.